Efficacy and Safety of Telitacicept for Prevention of Flares in SLE Patients
Clinical trial NCT06394063 · RECRUITING
Trial details
- NCT number
- NCT06394063
- Sponsor
- RenJi Hospital
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-28
- Primary completion
- 2027-06-30
- Enrollment
- 176
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.